FDA considers adding a dozen peptides to its bulk drug compounding list RAPS FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of BREAKING: FDA UPDATES CATEGORY 2 BULKS LIST OFFICIALLY REMOVES PEPTIDES LIKE BPC 157 The first opportunity for reclassification comes on July 23 24 during the FDA's PCAC meeting Until then, peptides are The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Peptide Craze Ground Truths When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions